C-Bridge Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

C-Bridge Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 6, 2024	3DC	$3.7M Series A Extension	—	Yuta Motoshima, Tomohiro Otsuki, Mitsubishi UFJ Capital, Junya Yasuda, Kazuto Hatano, Takasago Industry
Nov 16, 2023	Rutilea	$4.0M Series C	Abies Ventures	Last One Mile, Monozukuri Ventures, Shimadzu Future Innovation Fund, Star Mica Holdings, WingArc 1st
Apr 27, 2022	RVAC Medicines	$140.0M Series B	Wei Fu	Swee Yeok CHU, PBM, Suhhong Hur, Pavilion Capital
Jun 29, 2018	I-Mab Biopharma	$220.0M Mab Biopharma - Series C	Hony Capital	Ally Bridge Group, CDH Investments, EDBI, Hillhouse Capital, HOPU Investments
Jun 28, 2018	Nuance Biotech	$20.0M Series B	Wei Fu	—
May 8, 2018	BorderX Lab	$20.0M Series B	Eric Feng	Hillhouse Capital Group, Han Shen, Welight Capital
Apr 2, 2018	CMAB BioPharm	$34.0M Series B	—	Cormorant Asset Management, Tigermed
Jan 2, 2018	CMAB BioPharm	$38.0M Series A	BioBAY, Mengjiao Jiang	I-Bridge Capital
Jan 3, 2017	Ascletis	$100.6M Series B	C-Bridge Capital	FOCUS Media Jiangnanchun Foundation, Goldman Sachs, Tasly Pharmaceutical, WTT Investment